Cellect Biotechnology Ltd. is a company focused on enabling regenerative medicine through the mass enrichment of stem cells. Founded in 2011, its goal is to make quality stem cells easily available in mass for all medicinal purposes. Stem cells are recognized as the foundation of 21st century medicine, and without the necessary technologies to enable their mass enrichment, stem cell-based treatments will remain within the confines of laboratories and clinical trials. Cellect Biotechnology Ltd. is working to make regenerative medicine publicly available to all people through their groundbreaking technology.
Cellect Biotechnology Ltd.'s ticker is APOP
The company's shares trade on the NASDAQ stock exchange
They are based in Kfar Saba, Israel
There are 11-50 employees working at Cellect Biotechnology Ltd.
It is https://www.cellect.co/
Cellect Biotechnology Ltd. is in the Healthcare sector
Cellect Biotechnology Ltd. is in the Biotechnology industry
The following five companies are Cellect Biotechnology Ltd.'s industry peers: